Search results
Found 22820 matches for
Established in March 2020, the RECOVERY trial tests a range of potential treatments for COVID-19, including azithromycin, a widely used antibiotic that also reduces inflammation. The azithromycin arm of the trial was established to determine whether or not the drug has a meaningful benefit among patients hospitalised with COVID-19. A preliminary analysis shows no significant difference in the primary endpoint of 28-day mortality; there was also no evidence of beneficial effects on the risk of progression to mechanical ventilation or length of hospital stay.
Louise Thwaites
BSc MBBS MRCP MD DMSMed MLCOM Louise Thwaites - Professor of Experimental Critical Care
Raph Hamers
MD PhD Raph Hamers - Associate Professor in Infectious Diseases
Stuart Blacksell
BAppSc MPH PhD RBP(ABSA) FASM FFSc(RCPA) TechIOSH Stuart Blacksell - Professor of Tropical Microbiology
